A groundbreaking study has shed light on the intricate relationship between lactose consumption and the exacerbation of graft-versus-host disease (GVHD), a serious complication following allogeneic hematopoietic cell transplantation (allo-HCT). The research, which spans over 1,300 patients from four clinical centers, reveals that lactose can fuel the growth of certain gut bacteria, potentially heightening the risk and severity of GVHD. This discovery opens new avenues for dietary interventions to improve patient outcomes post-transplantation.
The gut microbiome is a complex and dynamic ecosystem within our bodies, playing a pivotal role in various physiological processes. It is involved in:
An imbalance in this delicate system can lead to a plethora of health issues, including gastrointestinal disorders like indigestion, diarrhea, and inflammatory bowel diseases, as well as metabolic conditions, infections, pancreatitis, asthma, cardiovascular diseases, autism, and even certain cancers, such as colorectal cancer.
Allo-HCT is a life-saving procedure for patients with hematologic malignancies. However, it carries the risk of GVHD, where donor T cells attack the recipient's body, primarily affecting the skin, liver, and intestines. Acute GVHD typically occurs within 100 days post-transplantation, with an incidence rate of 30% to 45%, while chronic GVHD develops later and is less common.
The study, published in Science under the title "Lactose drives Enterococcus expansion to promote graft-versus-host disease," involved a comprehensive analysis of patients undergoing allo-HCT. Researchers from the United States, Germany, and Japan discovered a correlation between higher levels of enterococci, particularly Enterococcus faecium, and increased GVHD incidence and mortality.
In both human patients and mouse models, the proliferation of enterococci in the gastrointestinal tract post-transplant was observed. This bacterial growth was linked to the presence of lactose, a disaccharide commonly found in dairy products. By removing lactose from the diet, the study demonstrated a reduction in enterococci growth, GVHD severity, and an improvement in survival rates in mice.
Furthermore, patients with a genetic predisposition to lactose malabsorption exhibited higher levels of enterococci. These individuals also showed a reduced ability to eliminate the bacteria after antibiotic treatment following allo-HCT.
This research highlights the potential impact of dietary lactose on the proliferation of specific gut bacteria that may contribute to the development and severity of GVHD. It suggests that dietary modifications, such as lactose restriction, could be a viable strategy to mitigate the risks associated with allo-HCT.
The findings also underscore the importance of personalized medicine, considering genetic factors like lactose malabsorption in patient care. As the study of the gut microbiome continues to evolve, it becomes increasingly clear that our diet can have profound effects on our health, particularly in the context of complex medical treatments like transplantation.
For more detailed information on the study, you can access the full article in Science here.
The intricate interplay between diet, gut microbiota, and disease outcomes is an emerging field of research with significant implications for patient care. This study's revelation about lactose's role in promoting enterococci growth and exacerbating GVHD provides a new perspective on dietary management post-transplantation. It opens the door for further research into how modifying one's diet can potentially improve the prognosis for transplant recipients.
ELife: T Interferon Suppresses Inflammatory Diseases by Balancing the Microbiome
Study found that STAT1KO mice spontaneously develop inflammatory diseases characterized by bone marrow hyperplasia and splenic accumulation of hematopoietic stem cells.
Proteins That Provide Key Information to Identify Patients with Poor Prognosis Found
Specific patterns or "signatures" of markers on the surface of immune cells in the blood may be biomarkers of immune checkpoint immunotherapy response, study found.
New Findings about BRD4 Protein You May Want to Know
How BRD4 (a protein that scientists have studied for many years) directs the spatial organization of DNA in the cell nucleus (a key function of stem cells to differentiate into muscle cells) has been clarified by a new study.
